2020
DOI: 10.1007/s10853-020-04365-4
|View full text |Cite
|
Sign up to set email alerts
|

Impact of a bioactive drug coating on the biocompatibility of magnesium alloys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…Following eqn (4) was used for calculation. 60 where OD T = OD of test specimen, OD NC = OD of negative control and OD PC = OD of positive control.…”
Section: Methodsmentioning
confidence: 99%
“…Following eqn (4) was used for calculation. 60 where OD T = OD of test specimen, OD NC = OD of negative control and OD PC = OD of positive control.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, in the LbL for Mg, it is necessary to avoid the use of biologically toxic substances. Quan et al [122] constructed the poly-β-hydroxybutyrate (PHB) coating containing vascular endothelial growth factor (VEGF) and heparin on the surface of WE Mg (Mg-4.1Y-2.8Nd-0.2Zn-0.4Zr) alloy using the LbL approach. The bioactive coating can effectively inhibit platelet adhesion and activation, thereby reducing the thrombosis.…”
Section: Biocompatible Coatingsmentioning
confidence: 99%
“…The author had researched and modified the PHB film to load bioactive drugs on the surface of magnesium alloys. 18 It can effectively improve biological activity, promote cell growth, and reduce the possibility of thrombosis. The purpose of this study was to improve the adhesive strength between PHB and magnesium alloys, and increase functionality.…”
Section: Introductionmentioning
confidence: 99%